Literature DB >> 16861706

Drug survival in rheumatoid arthritis.

D Mulherin, M Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16861706     DOI： 10.1093/rheumatology/kel245

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Discontinuation of methotrexate therapy in older patients with newly diagnosed rheumatoid arthritis: analysis of administrative health databases in Québec, Canada.

Authors:  Sasha Bernatsky; Debbie Ehrmann Feldman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 2.  The Duality of Economic Issues With Medication Non-adherence in Patients With Inflammatory Arthritis.

Authors:  Natasha K J Campbell; Khalid Saadeldin; Mary A De Vera
Journal:  Curr Rheumatol Rep       Date:  2017-09-18       Impact factor: 4.592

3.  Use of biological disease modifying antirheumatic drugs in rheumatoid arthritis in Austria from 2008 to 2011 : A retrospective analysis of 72% of the population.

Authors:  Tanja A Stamm; Berthold Reichardt; Jochen Zwerina; Valentin Ritschl; Valerie Nell-Duxneuner
Journal:  Wien Klin Wochenschr       Date:  2018-02-14       Impact factor: 1.704

Review 4.  Economics of non-adherence to biologic therapies in rheumatoid arthritis.

Authors:  Mary A De Vera; Jonathan Mailman; Jessica S Galo
Journal:  Curr Rheumatol Rep       Date:  2014-11       Impact factor: 4.592
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.